Bradshaw A D, Reed M J, Carbon J G, Pinney E, Brekken R A, Sage E H
Department of Vascular Biology, The Hope Heart Institute, University of Washington, Seattle, Washington 98104, USA.
Wound Repair Regen. 2001 Nov-Dec;9(6):522-30. doi: 10.1046/j.1524-475x.2001.00522.x.
The expression of SPARC (secreted protein acidic and rich in cysteine/osteonectin/BM-40) is elevated in endothelial cells participating in angiogenesis in vitro and in vivo. SPARC acts on endothelial cells to elicit changes in cell shape and to inhibit cell cycle progression. In addition, SPARC binds to and diminishes the mitotic activity of vascular endothelial growth factor. To determine the effect(s) of SPARC on angiogenic responses in vivo, we implanted polyvinyl alcohol sponges subcutaneously into wild-type and SPARC-null mice. On days 12 and 20 following implantation, SPARC-null mice showed increased cellular invasion of the sponges in comparison to wild-type mice. Areas of the sponge with the highest cell density exhibited the highest numbers of vascular profiles in both wild-type and SPARC-null animals. The endothelial component of the vessels was substantiated by immunoreactivity with three different markers specific for endothelial cells. Although sponges from SPARC-null relative to wild-type mice were populated by significantly more cells and blood vessels, an increase in the ratio of vascular to nonvascular cells was not apparent. No differences in the percentage of proliferating cells within the sponge were detected between wild-type and SPARC-null sections. However, elevated levels of vascular endothelial growth factor were associated with sponges from SPARC-null versus wild-type mice. An increase in vascular endothelial growth factor production was also observed in SPARC-null primary dermal fibroblasts relative to those of wild-type cells. In conclusion, we have shown that the fibrovascular invasion of polyvinyl alcohol sponges is enhanced in mice lacking SPARC, and we propose that increased levels of vascular endothelial growth factor account, at least in part, for this response.
分泌性酸性富含半胱氨酸蛋白(SPARC)/骨连接蛋白/BM - 40在参与体内外血管生成的内皮细胞中的表达升高。SPARC作用于内皮细胞,引起细胞形态变化并抑制细胞周期进程。此外,SPARC与血管内皮生长因子结合并降低其有丝分裂活性。为了确定SPARC对体内血管生成反应的影响,我们将聚乙烯醇海绵皮下植入野生型和SPARC基因敲除小鼠体内。植入后第12天和第20天,与野生型小鼠相比,SPARC基因敲除小鼠海绵体中的细胞浸润增加。在野生型和SPARC基因敲除动物中,细胞密度最高的海绵区域血管轮廓数量最多。通过与三种不同的内皮细胞特异性标记物的免疫反应证实了血管的内皮成分。尽管相对于野生型小鼠,来自SPARC基因敲除小鼠的海绵体中有更多的细胞和血管,但血管细胞与非血管细胞的比例增加并不明显。在野生型和SPARC基因敲除切片之间,未检测到海绵体内增殖细胞百分比的差异。然而,与野生型小鼠相比,SPARC基因敲除小鼠海绵体中血管内皮生长因子水平升高。相对于野生型细胞,在SPARC基因敲除的原代真皮成纤维细胞中也观察到血管内皮生长因子产生增加。总之,我们已经表明,在缺乏SPARC的小鼠中,聚乙烯醇海绵的纤维血管浸润增强,并且我们提出血管内皮生长因子水平的增加至少部分地解释了这种反应。